Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $521M | $591M | $676M | $714M | $539M | $880M | $1.09B | $1.32B | $1.45B | $1.49B |
| Revenue growth | — | 13.5% | 14.3% | 5.6% | -24.5% | 63.2% | 23.6% | 21.3% | 10.2% | 2.5% |
| Gross profit | $326M | $376M | $428M | $446M | $331M | $557M | $694M | $839M | $927M | $947M |
| Gross margin | 62.7% | 63.6% | 63.3% | 62.5% | 61.4% | 63.3% | 63.9% | 63.7% | 63.9% | 63.6% |
| Operating income | $66.7M | $78.6M | $94.7M | $105M | $70.1M | $148M | $194M | $251M | $275M | $270M |
| Operating margin | 12.8% | 13.3% | 14.0% | 14.7% | 13.0% | 16.8% | 17.9% | 19.1% | 18.9% | 18.2% |
| Net income | $33.3M | $41.6M | $53.8M | $60.2M | $38.2M | $87.4M | $121M | $153M | $164M | $168M |
| Net margin | 6.4% | 7.0% | 8.0% | 8.4% | 7.1% | 9.9% | 11.1% | 11.6% | 11.3% | 11.3% |
| EPS (diluted) | $1.07 | $1.33 | $1.71 | $1.90 | $1.21 | $2.75 | $3.78 | $4.75 | $5.12 | $5.24 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $54.6M | $35.9M | $63.0M | $76.5M | $65.0M | $120M | $73.0M | $106M | $188M | $215M |
| Capital expenditures | $4.78M | $3.02M | $3.96M | $5.43M | $11.0M | $141M | $33.8M | $6.46M | $4.74M | $24.4M |
| Free cash flow | $49.8M | $32.9M | $59.1M | $71.0M | $54.0M | -$21.7M | $39.3M | $99.3M | $183M | $190M |
| Share buybacks | $77.0K | — | — | — | — | — | — | — | — | — |
| Dividends paid | $18.0M | $21.2M | $26.3M | $34.6M | $20.8M | $31.7M | $63.7M | $80.0M | $96.0M | $103M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $162M | $208M | $193M | $133M | $170M | $160B | — | — | — | — |
| Total assets | $682M | $778M | $798M | $829M | $890M | $1.15B | $1.31B | $1.37B | $1.41B | $1.59B |
| Long-term debt | $53.1M | $36.2M | $22.9M | $10.7M | $10.1M | $133M | $151M | $128M | $116M | $121M |
| Shareholders' equity | $370M | $433M | $448M | $468M | $536M | $572M | $617M | $699M | $745M | $881M |
| Retained earnings | $403M | $423M | $449M | $475M | $504M | $561M | $620M | $694M | $763M | $829M |
| Shares (wtd avg diluted) | 31.2M | 31.3M | 31.5B | 31.7M | 31.7M | 31.8M | 32.0M | 32.1M | 32.1M | 32.1M |
Every figure is extracted from INTERPARFUMS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.